References

References for "Guidance on the intravenous use of colistimethate sodium (colistin) in adults"

  1. Tsuji BT, Pogue JM, Zavascki AP, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy 2019;39(1):10-39. doi: 10.1002/phar.2209 [published Online First: 2019/02/03]

  2. Chien HT, Lin YC, Sheu CC, et al. Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis. Int J Antimicrob Agents 2020;55(3):105889. doi: 10.1016/j.ijantimicag.2020.105889 [published Online First: 2020/01/11]

  3. Levy HG, Gould I et al. Detection, Treatment and Prevention of Carbapenemase-Producing Enterobacteriaceae: Recommendations for an International Working Group. Journal of Chemotherapy 2013, 25 (3): 129-140

  4. Summary of Product Characteristics (Colisitimethate Sodium 1 Million I.U. Powder for Solution for Injection, Beacon Pharmaceuticals / Kent Pharma UK Ltd. Last updated 01 May 2019. Accessed 09/09/22 via medicines.org.uk

  5. Summary of Product Characteristics (Colomycin 1 million International Units (IU) Powder for solution for injection, infusion or inhalation. Teva UK Ltd. Last updated 10/06/22. Accessed 04/11/22 via medicines.org.uk

  6. Gauthier et al. Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients. Antimicrob Agents Chemother 2012; 56 (5): 2392-2396  https://pubmed.ncbi.nlm.nih.gov/28011614/

  7. Pogue JM, Lee J et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis 2011; 53:879-84

  8. Gilbert DN. Polymyxin E, Colistin monograph. Last updated Nov 10 2020. Sanford Guide Web Edition. Accessed 04/11/22 via https://webedition.sanfordguide.com/en/drug-information/antibacterial-agents/polymyxins/polymyxin-e-colistin

  9. Nation RL et al. Dosing Guidance for Intravenous Colitin in Critically Ill Patients. Clin Infect Dis 2017 Mar 1;64(5): 565-571

  10. Colistimethate sodium monograph Version 3 – T1. Published 31/08/22. Medusa NHS Injectable Medicines Guide (Accessed 09/09/22)  https://medusa.wales.nhs.uk/

  11. Grayson ML. editor. Kucer’s the Use of Antibiotics 7th Boca Raton: CRC Press; 2017. Chapter: Polymyxins. (Accessed 06/11/22). Available from www.medicinescomplete.com

  12. Colistimethate Sodium. In IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Accessed 06/11/22. Available at micromedexsolutions.com

  13. Guideline Ranges for TDM 2022-2023 Version 1.8. 1st April 2022. Antimicrobial Reference Laboratory. Severn Pathology North Bristol NHS Trust nbt.nhs.uk/severn-pathology/pathology-services/antimicrobial-reference-laboratory